me/cfs

  1. forestglip

    Preprint iPSC-Derived Myogenic Progenitor Cells from People with ME/CFS Reveal Altered Genes and Pathways with Drug Repurposing Potential, 2026, Nguyen

    iPSC-Derived Myogenic Progenitor Cells from People with ME/CFS Reveal Altered Genes and Pathways with Drug Repurposing Potential Nguyen, Dao Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating multisystem disorder characterised by profound fatigue...
  2. Nightsong

    Exploring differences in protein cargo of extracellular vesicles from ME/CFS patient plasma compared to healthy controls, 2026, Rydland et al

    Abstract: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic and debilitating disease characterized by post-exertional malaise, fatigue and pain. Yet, its underlying biological mechanisms remain poorly understood. Extracellular vesicles (EVs) are nanoparticles carrying...
  3. forestglip

    Tryptophan Metabolism and Aryl‐Hydrocarbon Receptor Agonists in the Gut Microbiome of People With [ME/CFS], 2026, Esteban et al

    Tryptophan Metabolism and Aryl‐Hydrocarbon Receptor Agonists in the Gut Microbiome of People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic disease with unknown biological basis and no...
  4. forestglip

    Gastrointestinal symptoms correlate with core clinical features and systemic inflammation in [ME/CFS], 2026, Brown et al

    Gastrointestinal symptoms correlate with core clinical features and systemic inflammation in myalgic encephalomyelitis/chronic fatigue syndrome Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating multisystem illness marked by fatigue, cognitive impairment...
  5. forestglip

    Trial Report [...] adapted physical activity and therapeutic exercise programme in improving [CFS] in long COVID, [...] versus telerehabilitation, 2026, Kabir+

    Effectiveness of adapted physical activity and therapeutic exercise programme in improving chronic fatigue syndrome in long COVID, delivered via hospital-based rehabilitation versus telerehabilitation Background Long COVID is a prevalent condition characterised by pain, fatigue, disability...
  6. forestglip

    Self-management support needs for individuals with Myalgic Encephalomyelitis and their next of kin – a qualitative study, 2026, Grønning et al

    Self-management support needs for individuals with Myalgic Encephalomyelitis and their next of kin – a qualitative study Grønning, Kjersti; Lysfjord, Liv Eli; Røstad, Ann Katrin Hagen Background Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex, disabling condition...
  7. Nightsong

    ME/CFS and/or Long Covid in Aotearoa New Zealand: results from a food insecurity survey, 2026, Dey et al

    Abstract: Background Various chronic health conditions are associated with household vulnerability to food insecurity. There is limited evidence regarding the prevalence of food insecurity or the experiences and challenges related to nutrition and food access among people living with Myalgic...
  8. forestglip

    Preprint Stigmatisation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a scoping review, 2026, Vester et al

    Stigmatisation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a scoping review Patricia Vester, Stefanos Boudouroglou-Walter, Chantal Wieting, Jonas Schreyögg, Niklas Dammann, Annemarie Feißel, Katharina Piontek, Christine Blome Objective Myalgic Encephalomyelitis/Chronic...
  9. forestglip

    Overcoming barriers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome research: The CureME participatory model, 2026, Abken et al

    Overcoming barriers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome research: The CureME participatory model Ella Abken, Caroline Kingdon, Sarah Tyson Abstract Research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) presents unique challenges. These stem from the...
  10. forestglip

    Full recovery is possible: how women recover from [ME/CFS] outside formal clinical settings, 2026, Harper et al

    Full recovery is possible: how women recover from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) outside formal clinical settings Harper, Julie Aims Latest UK guidance for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) states there is no cure (NICE, 2021), leaving...
  11. forestglip

    Two-timepoint multidomain follow-up of post-COVID condition and ME/CFS: overlapping autonomic, small-fiber, and cognitive changes, 2026, Azcue et al

    Two-timepoint multidomain follow-up of post-COVID condition and ME/CFS: overlapping autonomic, small-fiber, and cognitive changes Background Post-COVID condition (PCC) and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) show marked clinical overlap, suggesting a shared...
  12. forestglip

    Raman Spectroscopy Combined with [ML] Reveals [ME]–Associated Biomolecular Signatures at Rest and After Standardized Stress, 2026, Heidarifard et al

    Raman Spectroscopy Combined with Machine Learning Reveals Myalgic Encephalomyelitis–Associated Biomolecular Signatures at Rest and After Standardized Stress Abstract Myalgic encephalomyelitis (ME) is characterized by profound fatigue, post-exertional malaise (PEM), and cognitive dysfunction...
  13. forestglip

    Long-Term Follow-Up of Women with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A 16-Year Longitudinal Study, 2026, Tomić et al

    Long-Term Follow-Up of Women with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A 16-Year Longitudinal Study Background and Objectives Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disorder characterized by persistent or relapsing fatigue lasting at...
  14. forestglip

    Benchmarking large language models for cell-free RNA diagnostic biomarker discovery, 2026, Gaudio et al

    Benchmarking large language models for cell-free RNA diagnostic biomarker discovery Abstract Large language models can synthesize biomedical knowledge, parse vast amounts of data, and generate code, positioning them as promising tools for biomarker discovery from high-throughput omics data...
  15. forestglip

    Significant aggravation of pre-existing [ME/CFS] following proton beam therapy for sphenoid wing meningioma: case report, 2026, Fischer et al

    Significant aggravation of pre-existing myalgic encephalomyelitis/chronic fatigue syndrome following proton beam therapy for sphenoid wing meningioma: case report Fischer, Christian; Seidlitz, Annekatrin; Krause, Mechthild Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)...
  16. forestglip

    Preprint Exploratory dried blood spot metabolomics identifies pathway-level convergence with ME/CFS biology in a self-reported PEM-like [...], 2026, Hauguel+

    Exploratory dried blood spot metabolomics identifies pathway-level convergence with ME/CFS biology in a self-reported PEM-like fatigue phenotype Hauguel, Pierrick; Anctil, Nicolas; Noel, Louis-Philippe Background Plasma and serum metabolomic studies of myalgic encephalomyelitis / chronic...
  17. forestglip

    Preprint [...] light exposure patterns and multidimensional health outcomes in individuals with [ME/CFS]: [...] prospective cohort study, 2026, Cambras et al

    Association between light exposure patterns and multidimensional health outcomes in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: findings from a prospective cohort study Background Light is a major environmental factor regulating circadian rhythms, sleep-wake cycles...
  18. forestglip

    Protocol Multimodal approach to identify neuropsychophysiological subgroups in [ME/CFS] and their relevance for rehabilitation: [protocol..], 2026, Dooms et al

    Multimodal approach to identify neuropsychophysiological subgroups in myalgic encephalomyelitis/chronic fatigue syndrome and their relevance for rehabilitation: protocol for a mechanistic cross-sectional and longitudinal study Introduction Myalgic Encephalomyelitis (ME)/Chronic Fatigue...
  19. forestglip

    Higher-order brain processes, rather than early processing, underlie sensory problems in ME/CFS: Evidence from ERPs, 2026, Frontiers in Medicine

    Higher-order brain processes, rather than early processing, underlie sensory problems in ME/CFS: Evidence from ERPs Sanjay Kumar, Alfred Veldhuis, Farzaneh Yazdani Introduction Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) experience significant sensory...
  20. forestglip

    Review The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID, 2026, Pucci et al

    The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID Practice Points 1. Use of low-dose naltrexone, typically dosed between 3 and 5 mg, is increasing in clinical practice for indications such as fibromyalgia, chronic pain syndrome, and post-COVID...
Back
Top Bottom